Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sino Biopharmaceutical Ltd (SMZ1.MU)

Munich - Munich Delayed Price. Currency in EUR
0.5328-0.0002 (-0.04%)
At close: 08:03AM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
27,701,313
26,861,356
23,647,224
24,234,030
20,888,584
Cost of Revenue
5,538,573
5,332,095
5,182,320
4,926,268
4,196,932
Gross Profit
22,162,740
21,529,261
18,464,904
19,307,762
16,691,652
Operating Expense
17,659,244
17,185,822
14,160,755
14,216,510
12,372,176
Operating Income
4,503,496
4,343,439
4,304,149
5,091,252
4,319,476
Net Non Operating Interest Income Expense
-145,069
-146,560
-129,365
27,759
9,459
Pretax Income
11,348,770
18,572,673
5,013,044
5,583,822
11,429,081
Tax Provision
1,192,360
1,957,880
672,377
889,448
696,236
Net Income Common Stockholders
8,049,109
14,608,412
2,771,086
2,706,794
9,046,347
Average Dilution Earnings
-530,913
-482,511
-
-
-
Diluted NI Available to Com Stockholders
7,518,196
14,125,901
2,771,086
2,706,794
9,046,347
Basic EPS
-
0.78
0.15
0.14
0.49
Diluted EPS
-
0.73
0.15
0.14
0.49
Basic Average Shares
-
18,768,650
18,800,284
18,811,056
18,548,557
Diluted Average Shares
-
19,282,955
18,800,284
18,811,056
18,548,557
Total Expenses
23,197,817
22,517,917
19,343,075
19,142,778
16,569,108
Net Income from Continuing & Discontinued Operation
8,049,109
14,608,412
2,771,086
2,706,794
9,046,347
Normalized Income
8,193,146
14,589,765
2,383,159
2,702,215
2,840,019
Interest Income
185,596
162,057
194,003
257,709
162,723
Interest Expense
330,665
308,617
323,368
229,950
153,264
Net Interest Income
-145,069
-146,560
-129,365
27,759
9,459
EBIT
11,679,435
18,881,290
5,336,412
5,813,772
11,582,345
EBITDA
11,679,435
-
-
-
-
Reconciled Cost of Revenue
5,538,573
5,332,095
5,182,320
4,926,268
4,196,932
Reconciled Depreciation
-
992,556
1,654,836
1,466,028
1,176,124
Net Income from Continuing Operation Net Minority Interest
8,049,109
14,608,412
2,771,086
2,706,794
9,046,347
Total Unusual Items Excluding Goodwill
-160,947
20,844
448,018
5,447
6,608,930
Total Unusual Items
-160,947
20,844
448,018
5,447
6,608,930
Normalized EBITDA
11,840,382
19,853,002
6,543,230
7,274,353
6,149,539
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-16,910
2,197
60,091
867.6536
402,602
Advertisement
Advertisement